{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T06:13:53Z","timestamp":1765260833436,"version":"3.46.0"},"reference-count":32,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background: Circulating sphingolipids have been implicated in central nervous system degenerative disorders, but their relationship with peripheral neuropathy remains unclear. Objectives: To evaluate associations between plasma sphingolipid levels and subsequent loss of vibration and light pressure sensation in the lower limbs of older adults. Methods: Plasma concentrations of 11 ceramide (Cer) and sphingomyelin (SM) species were measured in stored samples from 4612 participants in the Cardiovascular Health Study. Vibration sensation was assessed 4\u20136 years later in 2208 individuals using tuning fork testing, and light pressure sensation was evaluated 11\u201313 years later in 815 participants using monofilament testing. Sensory impairment was graded on a 3-point scale, with higher scores indicating greater loss. Ordinal logistic regression models examined associations between a doubling of sphingolipid levels and sensory decline, with stratification by diabetes status. Results: In primary models, no sphingolipid species showed significant associations with sensory outcomes. However, after adjusting for inflammatory markers, higher SM-16 levels were linked to increased odds of vibration sensation loss (OR 2.08; 95% CI: 1.11\u20133.90), while higher SM-24 levels were associated with reduced odds (OR 0.68; 95% CI: 0.46\u20130.998). Significant interactions with diabetes status were observed for light pressure sensation: SM-14 was associated with increased odds of sensory loss in participants with incident diabetes (OR 5.22; 95% CI: 1.58\u201317.29), and Cer-18 was associated with increased odds in those with prevalent diabetes (OR 2.38; 95% CI: 1.18\u20134.78). Conclusions: Elevated levels of specific ceramide and sphingomyelin species may be predictive of future peripheral sensory loss in older adults, with diabetes status influencing these associations.<\/jats:p>","DOI":"10.3390\/biomedicines13122995","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T09:17:36Z","timestamp":1765185456000},"page":"2995","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Associations of Circulating Sphingolipid Levels with Future Loss of Vibration and Light Pressure Sensation in the Lower Limb"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7044-4166","authenticated-orcid":false,"given":"Joshua I.","family":"Barzilay","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Kaiser Permanente of Georgia, Atlanta, GA 30096, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3403-8763","authenticated-orcid":false,"given":"Traci M.","family":"Bartz","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Washington, Seattle, WA 98195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"William T.","family":"Longstreth","sequence":"additional","affiliation":[{"name":"Departments of Neurology and Epidemiology, University of Washington, Seattle, WA 98195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4093-6036","authenticated-orcid":false,"given":"Elsa S.","family":"Strotmeyer","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6449-0243","authenticated-orcid":false,"given":"Andrew N.","family":"Hoofnagle","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0461-175X","authenticated-orcid":false,"given":"David","family":"Siscovick","sequence":"additional","affiliation":[{"name":"New York Academy of Medicine, New York, NY 10029, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8450-6970","authenticated-orcid":false,"given":"Kenneth J.","family":"Mukamal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Center, Brookline, MA 02215, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7038-1844","authenticated-orcid":false,"given":"Rozenn N.","family":"Lemaitre","sequence":"additional","affiliation":[{"name":"Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA 98101, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Hicks, C.W., Wang, D., Windham, B.G., Matsushita, K., and Selvin, E. (2021). Prevalence of peripheral neuropathy defined by monofilament insensitivity in middle-aged and older adults in two US cohorts. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-98565-w"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000542523","article-title":"The Association of Impaired Vibration Sensation in the Lower limb with Tests of Cognition in Older People. The Cardiovascular Health Study","volume":"54","author":"Barzilay","year":"2025","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/M20-1340","article-title":"Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults: A Prospective Cohort Study","volume":"174","author":"Hicks","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.mayocp.2015.05.004","article-title":"Peripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management","volume":"90","author":"Watson","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.12997\/jla.2021.10.3.268","article-title":"The complex tail of circulating sphingolipids in atherosclerosis and cardiovascular disease","volume":"21","author":"Zelnik","year":"2021","journal-title":"J. Lipid Atheroscler."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0163-7827(97)00008-8","article-title":"The role of sphingolipids in the process of signal transduction","volume":"36","author":"Riboni","year":"1997","journal-title":"Prog. Lipid Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tem.2017.03.005","article-title":"Sphingolipids and Lipoproteins in Health and Metabolic Disorders","volume":"28","author":"Iqbal","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ali-Berrada, S., Guitton, J., Tan-Chen, S., Gyulkhandanyan, A., Jajduch, E., and He Stunff, H. (2023). Circulating Sphingolipids and Glucose Homeostasis: An Update. Int. J. Med. Sci., 24.","DOI":"10.3390\/ijms241612720"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gomez-Larrauri, A., Larrea-Sebal, A., Mart\u00edn, C., and Gomez-Mu\u00f1oz, A. (2025). The critical roles of bioactive sphingolipids in inflammation. J. Biol. Chem., 301.","DOI":"10.1016\/j.jbc.2025.110475"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1515\/hsz-2022-0321","article-title":"Membrane damage and repair: A thin line between life and death","volume":"404","author":"Barisch","year":"2023","journal-title":"Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Hammad, S.M., and Lopes-Virella, M.F. (2023). Circulating Sphingolipids in Insulin Resistance, Diabetes and Associated Complications. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202308.1042.v1"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/bs.acr.2018.04.009","article-title":"Role and Function of Sphingomyelin Biosynthesis in the Development of Cancer","volume":"140","author":"Moorthi","year":"2018","journal-title":"Adv. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e012853","DOI":"10.1161\/JAHA.119.012853","article-title":"Plasma Ceramides and Sphingomyelins in Relation to Atrial Fibrillation Risk: The Cardiovascular Health Study","volume":"9","author":"Jensen","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e005708","DOI":"10.1161\/CIRCHEARTFAILURE.118.005708","article-title":"Plasma Ceramides and Sphingomyelins in Relation to Heart Failure Risk","volume":"12","author":"Jensen","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"ref_15","first-page":"e12623","article-title":"Circulating sphingolipids in relation to cognitive decline and incident dementia: The Cardiovascular Health Study","volume":"16","author":"Moseholm","year":"2024","journal-title":"Alzheimer\u2019s Dementia: Diagn. Assess. Dis. Monit."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Moseholm, K.F., Horn, J.W., Fitzpatrick, A.L., Djouss\u00e9, L., Longstreth, W.T., Lopez, O.L., Hoofnagle, A.N., Jensen, M.K., Lemaitre, R.N., and Mukamal, K.J. (2024). Circulating sphingolipids and subclinical brain pathology: The cardiovascular health study. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1385623"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chowdhury, M.D.R., Jin, H.K., and Bae, J.S. (2022). Diverse Roles of Ceramide in the Progression and Pathogenesis of Alzheimer\u2019s Disease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081956"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.addr.2020.04.009","article-title":"Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods","volume":"159","author":"Luo","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/jnc.15759","article-title":"Contribution of ceramides metabolism in psychiatric disorders","volume":"164","year":"2023","journal-title":"J. Neurochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/1047-2797(91)90005-W","article-title":"The Cardiovascular Health Study: Design and rationale","volume":"1","author":"Fried","year":"1991","journal-title":"Ann. Epidemiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"17339","DOI":"10.3390\/molecules200917339","article-title":"Biological and nutritional properties of palm oil and palmitic acid: Effects on health","volume":"20","author":"Mancini","year":"2015","journal-title":"Molecules"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tem.2011.12.004","article-title":"Insulin resistance in the nervous system","volume":"23","author":"Kim","year":"2012","journal-title":"Trends Endocrinol. Metabol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12035-013-8606-4","article-title":"Ceramide in the molecular mechanisms of neuronal cell death. The role of sphingosine-1-phosphate","volume":"50","author":"Czubowicz","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00011-019-01273-5","article-title":"The effect of palmitic acid on inflammatory response in macrophages: An overview of molecular mechanisms","volume":"68","author":"Korbecki","year":"2019","journal-title":"Inflamm. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.bbamcr.2014.04.004","article-title":"Oleate prevents palmitate-induced mitochondrial dysfunction, insulin resistance and inflammatory signaling in neuronal cells","volume":"1843","author":"Kwon","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/09687860601127770","article-title":"Sphingomyelin chain length influences the distribution of GPI-anchored proteins in rafts in supported lipid bilayers","volume":"24","author":"Garner","year":"2007","journal-title":"Mol. Membr. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.febslet.2009.10.058","article-title":"Sphingomyelin metabolism at the plasma membrane: Implications for bioactive sphingolipids","volume":"584","author":"Milhas","year":"2010","journal-title":"FEBS Lett."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12017-016-8423-9","article-title":"Increased Plasma Levels of Select Deoxy-ceramide and Ceramide Species are Associated with Increased Odds of Diabetic Neuropathy in Type 1 Diabetes: A Pilot Study","volume":"19","author":"Hammad","year":"2017","journal-title":"Neuromolecular Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11306-022-01879-7","article-title":"Sphingolipid metabolism plays a key role in diabetic peripheral neuropathy","volume":"18","author":"Song","year":"2022","journal-title":"Metabolomics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/acn3.51367","article-title":"Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetes","volume":"8","author":"Rumora","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/acn3.51639","article-title":"Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes","volume":"9","author":"Afshinnia","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Wang, Z., Liu, Z., Yang, Q., Qiao, H., Yin, Y., Zhao, Z., and Shao, X. (2025). Causal relationships between plasma lipidome and diabetic neuropathy: A Mendelian randomization study. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1398691"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/12\/2995\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T05:17:24Z","timestamp":1765257444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/12\/2995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["biomedicines13122995"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13122995","relation":{},"ISSN":["2227-9059"],"issn-type":[{"type":"electronic","value":"2227-9059"}],"subject":[],"published":{"date-parts":[[2025,12,6]]}}}